Order Article Reprints

Kolosova EA, Shaprova ON, Shanshin DV, Nesmeyanova VS, Merkuleva IA, Belenkaya SV, Isaeva AA, Nikitin AO, Volosnikova EA, Nikulina YA, et al. Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19. Journal of Clinical Medicine. 2022; 11(14):4053. https://doi.org/10.3390/jcm11144053

Kolosova, Evgeniia A., Olga N. Shaprova, Daniil V. Shanshin, Valentina S. Nesmeyanova, Iuliia A. Merkuleva, Svetlana V. Belenkaya, Anastasiya A. Isaeva, Artem O. Nikitin, Ekaterina A. Volosnikova, Yuliya A. Nikulina, and et al. 2022. "Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19" Journal of Clinical Medicine 11, no. 14: 4053. https://doi.org/10.3390/jcm11144053

Kolosova, E. A., Shaprova, O. N., Shanshin, D. V., Nesmeyanova, V. S., Merkuleva, I. A., Belenkaya, S. V., Isaeva, A. A., Nikitin, A. O., Volosnikova, E. A., Nikulina, Y. A., Nikonorova, M. A., Shcherbakov, D. N., & Elchaninova, S. A. (2022). Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19. Journal of Clinical Medicine, 11(14), 4053. https://doi.org/10.3390/jcm11144053